Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
10.08
+1.34 (15.33%)
At close: Dec 20, 2024, 4:00 PM
10.06
-0.02 (-0.20%)
After-hours: Dec 20, 2024, 7:14 PM EST
Ginkgo Bioworks Holdings Employees
Ginkgo Bioworks Holdings had 1,218 employees as of December 31, 2023. The number of employees decreased by 74 or -5.73% compared to the previous year.
Employees
1,218
Change (1Y)
-74
Growth (1Y)
-5.73%
Revenue / Employee
$178,942
Profits / Employee
-$534,638
Market Cap
535.07M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,218 | -74 | -5.73% |
Dec 31, 2022 | 1,292 | 651 | 101.56% |
Dec 31, 2021 | 641 | 146 | 29.49% |
Dec 31, 2020 | 495 | - | - |
Related Stocks
Company Name | Employees |
---|---|
InnovAge Holding | 2,350 |
MeiraGTx Holdings | 425 |
Sangamo Therapeutics | 405 |
UroGen Pharma | 201 |
AnaptysBio | 117 |
Kodiak Sciences | 111 |
Alumis | 109 |
Theravance Biopharma | 99 |
DNA News
- 4 days ago - Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program - PRNewsWire
- 4 weeks ago - Ginkgo Bioworks: Unproven Transition But 2025 Is Looking Better - Seeking Alpha
- 5 weeks ago - Ginkgo Bioworks: Not Enough Progress - Seeking Alpha
- 5 weeks ago - Ginkgo Bioworks Holdings, Inc. (DNA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Ginkgo Bioworks Reports Third Quarter 2024 Financial Results - PRNewsWire
- 5 weeks ago - Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing - PRNewsWire
- 6 weeks ago - Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation - PRNewsWire
- 2 months ago - Ginkgo Bioworks (DNA) Shares Drop Amid Weak Earnings and Sell Ratings - GuruFocus